title: Paving a regulatory pathway for phage therapy. Europe should muster the resources to financially, technically and legally support the introduction of phage therapy.
authors.affiliation: Department of Pharmaceutical and Pharmacological Sciences, KU Leuven in Leuven, Belgium.
authors.forename: Isabelle
authors.initials: I
authors.lastname: Huys
authors.forename: Jean-Paul
authors.initials: JP
authors.lastname: Pirnay
authors.forename: Rob
authors.initials: R
authors.lastname: Lavigne
authors.forename: Serge
authors.initials: S
authors.lastname: Jennes
authors.forename: Daniel
authors.initials: D
authors.lastname: De Vos
authors.forename: Minne
authors.initials: M
authors.lastname: Casteels
authors.forename: Gilbert
authors.initials: G
authors.lastname: Verbeken
mesh_terms: D000900:Anti-Bacterial Agents / Q000191:economics*; D001424:Bacterial Infections / Q000628:therapy* / Q000821:virology*; D001435:Bacteriophages / Q000502:physiology*; D005060:Europe; D006801:Humans; D007878:Legislation as Topic; D012926:Social Control, Formal; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents